ESC 2025 Highlights
The first part of this two-part webinar features key highlights from the ESC Congress 2025. Prof. Deepak Bhatt provides an in-depth analysis of several significant trials, including DAPA-ACT, BETAMI-DANBLOCK, REBOOT-CNIC, PANTHER, VICTORIAN-Difference, NEWTON-CABG CardioLink-5, and REDUCE-IT. Moreover, he explores critical aspects of dyslipidaemia, drawing from the 2025 focused update guideline published by the ESC. The second part of the webinar is dedicated to addressing questions from the audience.
Lipoprotein(a) in Atherosclerotic Cardiovascular Disease: Current Perspectives on Prevalence, Risk Assessment, and Management
In this video, Prof. Lale Tokgozoglu presents an infographic on Lp(a).
The Future of ASCVD and Lipidology with Prof. Cannon
In this video, Prof. Christopher Cannon explored the future of ASCVD and lipidology. He talks about the recent expanded indication for evlocumab and new indication for inclisiran, upcoming guidelines on LDL management, the development of oral PCSK9 inhibitors, CETP inhibitors, upcoming trials on Lp(a), and strategies for managing triglycerides.
The Future of ASCVD and Lipidology with Prof. Bhatt
In this video, Prof. Deepak Bhatt discusses the future of ASCVD and Lipidology.
Video Library
Watch educational videos to visually grasp complex ASCVD concepts and treatments
Video Library
Role of Eicosanoids in Atherosclerosis, with a Focus on Icosapent Ethyl (IPE) as a Therapeutic Option for Cardiovascular Disease
In this video, Prof. Deepak L. Bhatt presents an infographic on the role of eicosanoids in atherosclerosis with a focus on IPE as therapeutic option for CVD.
Webinars
Watch webinar recordings on the subject of ASCVD concepts and treatments
Webinars
European Society of Cardiology (ESC) Congress 2024 – Highlights
Prof. Deepak Bhatt and Prof. Yi-Heng Li discuss the highlights from ESC Congress 2024. They present and discuss the findings related to lipid lowering therapy, as well as the latest guidelines and approaches for managing chronic coronary symptoms.
Infographics
Browse through infographics for quick, visual summaries of key ASCVD information
Articles
Read in-depth articles and whitepapers for a detailed analysis of ASCVD topics.
Case Studies
Apply your knowledge by working through real-world ASCVD case studies
Case Studies
August 2023
Take this short quiz to test your knowledge on the recently published debate on dyslipidemias titled “Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers”.
CLICK HERE TO VIEW THE DEBATE.
Eur Heart J. 2023 Jul 1;44(25):2292-2304. doi: 10.1093/eurheartj/ehad275
Faculty
Kyung Woo Park, MD, PhD, MBA
Professor of Medicine
MORE
Department of Internal Medicine, Cardiovascular Center
Seoul National University Hospital & Seoul National University College of Medicine, Seoul, KoreaKhalid Fayez Alhabib, MBBS, FRCPC
King Fahad Cardiac Center, College of Medicine, King Saud University, Saudi Arabia
MOREChristopher P. Cannon, MD
Senior Physician, Brigham and Women’s Hospital
More
Professor of Medicine, Harvard Medical School
Education Director in the Cardiovascular Innovation groupS. Lale Tokgözoğlu, M.D., F.A.C.C., F.E.S.C
Professor of Cardiology, Hacettepe University
More
Immediate Past-President of the European Atherosclerosis SocietyDeepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI
Director of Mount Sinai Heart Hospital and the Cardiovascular Institute, Professor | Medicine, Cardiology
MoreStephen Nicholls, MBBS, PhD, FRACP, FACC, FESC, FAHA, FCSANZ, FAHMS
Director of MonashHeart
More
Director of Victorian Heart Institute
Professor of Cardiology at Monash UniversityYi-Heng Li, MD, PhD, FACC, FESC
Senior attending physician, Division of Cardiology, National Cheng Kung University Hospital, Tainan, Taiwan
MORE
Professor, Department of Internal Medicine, University’s College of Medicine
Stay up to date
Join the Wiley Knowledge Hub mailing list to stay up to date with the latest research and education in your area of interest.
JOIN NOW